The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome Diamanti-Kandarakis E et al. - The polycystic ovary syndrome (PCOS), a prevalent endocrinopathy of women, has been associated with a clustering of adverse metabolic features, which co-exist with reproductive dysfunction. Lipid abnormalities are very common in lean as well as obese women with PCOS and should be cautiously considered in the therapeutic management of the syndrome. [more...]
